World News
-
WHO recommends 2027 Southern Hemisphere influenza vaccine composition
WHO bases its recommendations on surveillance data collected through the Global Influenza Surveillance and Response System (GISRS), supported by collaborating centres and essential regulatory laboratories.
-
African leaders call for stronger domestic malaria financing at UNGA 81
ALMA and Malaria No More UK estimate that a 30% reduction in malaria financing could result in 146 million additional cases, almost 400,000 additional deaths and US$37 billion in lost economic output by 2030.
-
Genentech signs US$1.5B Earendil deal to develop AI-designed bispecific antibodies
Earendil, a biotechnology company operating in the US and China, will identify and develop bispecific antibody programmes based on target combinations agreed with Genentech.
-
Aptar Pharma partners with Macquarie University on dry powder inhaled biologics
The collaboration comes as pharmaceutical developers explore alternative delivery routes for biologic medicines, which can present formulation and administration challenges because of their molecular size and complexity.
-
Singapore’s AIGP Health expands clinical AI platform Anzu into Thailand
AIGP Health designed Anzu to help clinicians access relevant patient information and clinical context during consultations.
-
PAHO together with Africa CDC calls for sustained pandemic financing at UN General Assembly
The meeting brought together leaders and partners from both regions to discuss how country led priorities, stronger regional capacity and predictable financing can strengthen health systems and improve preparedness for future health emergencies.
-
Mayo Clinic uncovers novel biomarkers for lung adenocarcinoma treatment success
Lung adenocarcinoma is the most common form of lung cancer and can occur in both smokers and people who have never smoked.
-
Boehringer Ingelheim sells China biologics CDMO unit to Shanghai RAAS
Shanghai-based Raas disclosed the proposed acquisition in a financial filing, stating that it plans to acquire a 100% stake in Boehringer Ingelheim Biopharmaceuticals in China.
-
Africa CDC urges rapid delivery of US$2.9B Ebola funding mobilized in New York
The European Union has mobilised €500 million (US$586 million) in emergency aid, vaccines, treatment and health security support for the Great Lakes and Uganda region.
-
Novartis licenses preclinical radioligand asset from China’s BoomRay in US$900M global deal
The agreement brings together BoomRay’s expertise in radioligand therapy development and Novartis’ global capabilities in radiopharmaceutical research and commercialisation.